A Registration Trend in Eyelid Skin Cancers and Associated Risk Factors in Iran, 2005-2016

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2023 Sep 30

PMID 37777736

Authors

Sare Safi

Mohadese Ahmadzade

Saeed Karimi

Mohammad Esmaeil Akbari

Hamidreza Rouientan

Mohammad Abolhosseini

Mozhgan Rezaei Kanavi

Zahra Khorrami

Affiliations

Soon will be listed here.

Abstract

Background: Eyelid skin cancers are the most prevalent ophthalmic malignancies. This study aimed to evaluate the association of the Human Development Index (HDI) and lifestyle risk factors with eyelid skin cancers in Iran.

Methods: This ecological study analyzed the data collected from the Iranian National Population-based Cancer Registry (2005-2016). The data on provincial-level eyelid skin cancer risk factors were obtained from national sources. The association between provincial HDI and lifestyle risk factors with the prevalence of eyelid skin cancers was assessed.

Results: The mean 12-year age-standardized incidence rate (ASIR) of eyelid skin cancers was 16.22 per 100,000 (9,104 cases). The overall ASIR showed an upward trend with an estimated annual average increase of 0.006 per year. There were positive correlations between the prevalence of overall eyelid skin cancers and provincial HDI, smoking, and obesity (r = 0.32, 0.42, and 0.37, respectively). In multivariate analysis, obesity/overweight remained a positive predictor for high prevalence of total eyelid skin cancers (OR = 1.97, 95%CI = 1.08-3.58, P = 0.026), carcinoma (2.10, 1.15-3.83, P = 0.015), and basal cell carcinoma (1.48, 0.99-2.20, P = 0.054).

Conclusions: An increasing trend in ASIR of eyelid skin cancers was observed in more than a decade in Iran which was positively associated with provincial HDI and prevalence of obesity. The findings of the study highlight the importance of promotional programs for preventing obesity/overweight and appropriate allocation of screening facilities based on the HDI level.

References

Jin G, Liu Y, Jin S, Liu X, Liu S . UVB induced oxidative stress in human keratinocytes and protective effect of antioxidant agents. Radiat Environ Biophys. 2007; 46(1):61-8. DOI: 10.1007/s00411-007-0096-1. View

Kirkpatrick C, White E, Lee J . Case-control study of malignant melanoma in Washington State. II. Diet, alcohol, and obesity. Am J Epidemiol. 1994; 139(9):869-80. DOI: 10.1093/oxfordjournals.aje.a117093. View

Danaei G, Farzadfar F, Kelishadi R, Rashidian A, Rouhani O, Ahmadnia S . Iran in transition. Lancet. 2019; 393(10184):1984-2005. DOI: 10.1016/S0140-6736(18)33197-0. View

Sergentanis T, Antoniadis A, Gogas H, Antonopoulos C, Adami H, Ekbom A . Obesity and risk of malignant melanoma: a meta-analysis of cohort and case-control studies. Eur J Cancer. 2012; 49(3):642-57. DOI: 10.1016/j.ejca.2012.08.028. View

Mills C, Hill S, Marks R . Transdermal nicotine suppresses cutaneous inflammation. Arch Dermatol. 1997; 133(7):823-5. View

Lu L, Wan B, Zeng H, Guo J, Li M, Sun M . Body mass index and the risk of basal cell carcinoma: evidence from Mendelian randomization analysis. PeerJ. 2023; 11:e14781. PMC: 9881466. DOI: 10.7717/peerj.14781. View

Gallus S, Naldi L, Martin L, Martinelli M, La Vecchia C . Anthropometric measures and risk of cutaneous malignant melanoma: a case-control study from Italy. Melanoma Res. 2006; 16(1):83-7. DOI: 10.1097/01.cmr.0000194429.77643.76. View

Roshandel G, Ghanbari-Motlagh A, Partovipour E, Salavati F, Hasanpour-Heidari S, Mohammadi G . Cancer incidence in Iran in 2014: Results of the Iranian National Population-based Cancer Registry. Cancer Epidemiol. 2019; 61:50-58. DOI: 10.1016/j.canep.2019.05.009. View

Kaliki S, Das A . Ocular and Periocular Tumors in India: An EyeSmart Electronic Medical Record Analysis of 9633 Cases from a Referral Center. Middle East Afr J Ophthalmol. 2021; 27(4):199-203. PMC: 7993046. DOI: 10.4103/meajo.MEAJO_275_19. View

10.

Staples M, Elwood M, Burton R, Williams J, Marks R, Giles G . Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006; 184(1):6-10. DOI: 10.5694/j.1326-5377.2006.tb00086.x. View

11.

Samanic C, Chow W, Gridley G, Jarvholm B, Fraumeni Jr J . Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control. 2006; 17(7):901-9. DOI: 10.1007/s10552-006-0023-9. View

12.

Maccioni L, Rachakonda P, Scherer D, Lorenzo Bermejo J, Planelles D, Requena C . Variants at chromosome 20 (ASIP locus) and melanoma risk. Int J Cancer. 2012; 132(1):42-54. DOI: 10.1002/ijc.27648. View

13.

Bas Z, Sharpe J, Yaghy A, Zhang Q, Shields C, Hyman L . Prevalence of and Associated Factors for Eyelid Cancer in the American Academy of Ophthalmology Intelligent Research in Sight Registry. Ophthalmol Sci. 2022; 3(1):100227. PMC: 9692036. DOI: 10.1016/j.xops.2022.100227. View

14.

Siegel R, Miller K, Fuchs H, Jemal A . Cancer statistics, 2022. CA Cancer J Clin. 2022; 72(1):7-33. DOI: 10.3322/caac.21708. View

15.

Jung S, Lim J, Yang S, Jee D, Won Y . Nationwide Trends in the Incidence and Survival of Eyelid Skin Cancers in Korea. Ophthalmic Epidemiol. 2020; 27(6):438-448. DOI: 10.1080/09286586.2020.1767152. View

16.

Karimi K, Lindgren T, Koch C, Brodell R . Obesity as a risk factor for malignant melanoma and non-melanoma skin cancer. Rev Endocr Metab Disord. 2016; 17(3):389-403. DOI: 10.1007/s11154-016-9393-9. View

17.

Alfaar A, Suckert C, Rehak M, Girbardt C . The epidemiology of adults' eyelid malignancies in Germany between 2009 and 2015; An analysis of 42,710 patients' data. Eur J Ophthalmol. 2022; :11206721221125018. PMC: 9999282. DOI: 10.1177/11206721221125018. View

18.

Cook Jr B, Bartley G . Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota. Ophthalmology. 1999; 106(4):746-50. DOI: 10.1016/S0161-6420(99)90161-6. View

19.

Katta R, Brown D . Diet and Skin Cancer: The Potential Role of Dietary Antioxidants in Nonmelanoma Skin Cancer Prevention. J Skin Cancer. 2015; 2015:893149. PMC: 4637095. DOI: 10.1155/2015/893149. View

20.

Lin H, Cheng C, Hsu W, Kao W, Chou P . Incidence of eyelid cancers in Taiwan: a 21-year review. Ophthalmology. 2006; 113(11):2101-7. DOI: 10.1016/j.ophtha.2006.06.001. View